T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLTX
426
DELISTED
Fleetmatics Group PLC
FLTX
| $216M | 0.04% |
4,604,543
-138,400
| -3% | -$6.13M |
|
427
Home BancShares
HOMB
$6.27B
| $215M | 0.04% |
11,760,294
-355,040
| -3% | -$6.14M |
|
|
TSRO
428
DELISTED
TESARO, Inc.
TSRO
| $212M | 0.04% |
3,606,542
+68,018
| +2% | +$3.9M |
|
|
KRFT
429
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $211M | 0.04% |
2,483,538
+641,687
| +35% | +$55.2M |
|
|
PSB
430
DELISTED
PS Business Parks, Inc.
PSB
| $211M | 0.04% |
2,930,448
+153,363
| +6% | +$11.7M |
|
431
Insmed
INSM
$27.6B
| $211M | 0.04% |
8,653,627
+282,480
| +3% | +$6.41M |
|
432
Shutterstock
SSTK
$217M
| $210M | 0.04% |
3,584,838
+182,456
| +5% | +$11.9M |
|
|
EIGI
433
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $210M | 0.04% |
10,169,242
+1,475,163
| +17% | +$30.8M |
|
|
P
434
DELISTED
Pandora Media Inc
P
| $210M | 0.04% |
13,495,732
-1,402,653
| -9% | -$24.6M |
|
435
CenterPoint Energy
CNP
$26.7B
| $209M | 0.04% |
11,004,906
+2,274,047
| +26% | +$46M |
|
436
BP
BP
$110B
| $207M | 0.04% |
6,169,210
-405,689
| -6% | -$14.2M |
|
|
YHOO
437
DELISTED
Yahoo Inc
YHOO
| $207M | 0.04% |
5,265,672
-600,778
| -10% | -$25.8M |
|
438
Mettler-Toledo International
MTD
$28.7B
| $206M | 0.04% |
603,423
-6,584
| -1% | -$2.17M |
|
439
Alnylam Pharmaceuticals
ALNY
$30.4B
| $205M | 0.04% |
1,711,294
+449,690
| +36% | +$53.7M |
|
|
WBC
440
DELISTED
WABCO HOLDINGS INC.
WBC
| $205M | 0.04% |
1,655,498
-864,832
| -34% | -$109M |
|
441
Mercado Libre
MELI
$92.7B
| $204M | 0.04% |
1,442,695
-120,988
| -8% | -$17.1M |
|
|
MKTO
442
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $204M | 0.04% |
7,262,271
-164,276
| -2% | -$4.71M |
|
|
DPLO
443
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $203M | 0.04% |
4,538,301
-323,507
| -7% | -$12.2M |
|
444
TJX Companies
TJX
$170B
| $203M | 0.04% |
6,136,286
-113,000
| -2% | -$3.76M |
|
445
Burlington
BURL
$22.4B
| $201M | 0.04% |
3,916,777
+2,774,479
| +243% | +$148M |
|
446
Goldman Sachs
GS
$304B
| $200M | 0.04% |
956,307
-20,541
| -2% | -$4.19M |
|
447
TripAdvisor
TRIP
$1.29B
| $199M | 0.04% |
2,284,555
+68,248
| +3% | +$5.55M |
|
448
Colgate-Palmolive
CL
$74.1B
| $199M | 0.04% |
3,041,397
+579,161
| +24% | +$39.3M |
|
449
East-West Bancorp
EWBC
$18.6B
| $199M | 0.04% |
4,435,721
-841,640
| -16% | -$36.1M |
|
450
Fortinet
FTNT
$121B
| $198M | 0.04% |
23,977,535
-100,640
| -0.4% | -$782K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.